Education, Science, Technology, Innovation and Life
Open Access
Sign In

Perspectives of gene editing for cancer treatments, in addition to casual cancer therapies

Download as PDF

DOI: 10.23977/behdp.2021038

Author(s)

Shuhao Cao, Sang Yu, Yufei Li

Corresponding Author

Shuhao Cao

ABSTRACT

Nowadays, a surge in the number of human diseases has been marked treatable with advanced medical technologies. However, there is still a considerable number of diseases that today's medical level cannot heal. Cancer, one of the diseases that can hardly be treated, has received considerable attention. Cancer is a genetic disease caused by the uncontrolled growth of abnormal cells in the body, which can be caused when normal control mechanisms of the body stop working. This paper aims to introduce the newly developing technology – gene editing (CRISPR is one of the main ideas). In the recent 30 years, CRISPR was investigated and quickly developed, which provides the idea of treating cancer by modifying DNA sequences. However, this technology is not mature enough, requiring further research and experiments to determine whether CRISPR can be used safely on human genetic diseases. The paper provides a brief background of the cancer mechanisms and introduces current treatments such as Chemanol therapy, immunotherapy, radiotherapy, and hormonal therapy with targeted medicine.

KEYWORDS

Cancer treatments, gene editing, CRISPR, vectors, advanced therapy

All published work is licensed under a Creative Commons Attribution 4.0 International License.

Copyright © 2016 - 2031 Clausius Scientific Press Inc. All Rights Reserved.